Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...

Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.

Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

Microdosing GLP-1 has been touted for everything for weight management to perimenopause symptoms. But is it all it’s cracked ...

Artificial sweeteners, specifically aspartame, are under scrutiny following a WHO classification as 'possibly carcinogenic to ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...